Surprise: These 3 Large-Cap Stocks Have Outperformed Nvidia Stock in 2024
These stocks are up big, but that doesn't mean that they can't go up even more.
More Interest Rate Cuts Ahead: 5 Growth Stocks to Benefit
These fives stocks have strong growth potential for the rest of 2024. These are: APP, DUOL, PARAA, TWLO, CTLT.
AppLovin Stock Gains 228% YTD: Should You Buy or Wait for a Dip?
Given the continued strength in APP shares, we analyze its current position to determine whether it presents a good investment opportunity at this time.
After Soaring 224% in 2024, Is It Too Late to Buy AppLovin Stock?
Investors are sometimes cautious when approaching a stock that has increased by this magnitude.
AppLovin Finds Customers Acquired Through In-App Ads More Engaged, Loyal Than Those Acquired By Social Media
PALO ALTO, Calif.--(BUSINESS WIRE)--AppLovin's new report explains how consumer mobile apps and direct-to-consumer brands can leverage mobile in-app advertising to deliver new growth.
AppLovin's Profitability And Free Cash Flow: A Recipe For Stock Success
AppLovin's stock has surged over 200% YTD, driven by high FCF growth, revenue growth, and strategic share buybacks. The company's expansion into e-commerce and other verticals, leveraging its Axon ...
AppLovin Can Grow As Marketing Budgets Shrink
AppLovin's AI-native, data-driven platform is well-positioned to thrive as more marketing dollars shift to digital platforms. AppLovin's advanced recommendation engine aligns with CMOs' needs for c...
Forget Nvidia: Consider These 3 Millionaire-Maker Stocks to Buy Instead
SoundHound AI aims to become the standard for AI voice-recognition technology. Cybersecurity provider SentinelOne has a big opportunity to take advantage of CrowdStrike's IT outage fiasco.
Best Growth Stocks to Buy for September 13th
POWL, NCLH, and APP made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 13, 2024.
AppLovin Stock Rises 117% YTD: Should you Buy or Wait for a Pullback?
Given the continued surge in APP shares, we evaluate the stock's current position to determine how to play it now.
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercializ...
TAIPEI , Sept. 9, 2024 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (hereinafter referred to as "Formosa Pharma," 6838.TW) announced the successful first shipment to the United States of its new o...
Earnings Estimates Rising for AppLovin (APP): Will It Gain?
AppLovin (APP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Market Rebound: 3 Stocks to Buy for the Next Leg Higher
Last week the market experienced one of the fastest rises in volatility since the Covid-19 pandemic and the Great Financial Crisis. The VIX index rose above 60 on Monday morning, which was a 40-poi...
Investors Love AppLovin After Strong Growth. Is It Too Late to Buy the Stock?
AppLovin reported strong Q2 growth once again powered by its Axon 2 AI-based advertising technology. The company has a huge opportunity as it looks to apply this technology to other markets outside...
Related Companies